04:45 PM EST - Aeterna Zentaris Inc. : announced that an interim review of a Phase 3 trial of AEZS-130, demonstrates the compound may provide a simple, well-tolerated and safe oral diagnostic test for Adult Growth Hormone Deficiency. Aeterna Zentaris Inc.
shares T.AEZ are trading even at $1.31.
